Treatment - Group 3—Monomethylhydrazine (Gyromitrin)

How to Subscribe
MLS & MLT Comprehensive CE Package
Includes 145 CE courses, most popular
$95Add to cart
Pick Your Courses
Up to 8 CE hours
$50Add to cart
Individual course$20Add to cart
Need multiple seats for your university or lab? Get a quote
The page below is a sample from the LabCE course Mushroom Poisoning and the Laboratory's Role in Monitoring Patients. Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about Mushroom Poisoning and the Laboratory's Role in Monitoring Patients (online CE course)
Treatment - Group 3—Monomethylhydrazine (Gyromitrin)

Fortunately Group 3 poisonings account for only 1% of all mushroom poisonings in the United States. The percentages are higher in European countries. Benzodiazepines or pyridoxine may be administered IV to overcome seizures. Since hydrazine inhibits the transformation of folic acid, patients with severe Group 3 toxicity should be given folic acid as an adjunctive therapy. Patients should be closely monitored for further complications such as potential destruction of skeletal muscle, methemoglobinemia, and hemolysis.